Harkarandeep Singh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Date Time
Share
New evidence sheds light on best practices for treating patients with severe respiratory failure from COVID-19
Findings suggest ECMO life-support therapy can improve odds of survival for patients critically ill with COVID-19
BOSTON – COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020. Patients with severe COVID-19 frequently experience respiratory distress and require assistance breathing. For patients whose lungs are so injured that even a ventilator is unable to deliver enough oxygen, extracorporeal membrane oxygenation (ECMO) which does the work of the lungs by removing carbon dioxide and adding oxygen to blood outside the body may improve the odds of survival for certain patients with severe COVID-19. ....

United States , Harkarandeep Singh , Wei Wang , Shahzad Shaefi , Brianp Ogara , Tanveer Shaukat , Meganl Krajewski , Shruti Gupta , National Institute Of Health , Beth Israel Deaconess Medical Center , World Health Organization , Professor Of Medicine At Harvard Medical School , Translational Research In Acute Kidney Injury , Division Of Renal Medicine , Department Of Anesthesia , Professor In Anesthesia At Harvard Medical School , Intensive Care Medicine , Critical Care , Critically Ill Patients , Translational Research , Acute Kidney Injury , Renal Medicine , Assistant Professor , Harvard Medical , Sedana Medical , National Institute ,